Latest Breaking News On - மழை லெஹ்மன் - Page 1 : comparemela.com

Sartorius continues on its fast growth trajectory - significant double-digit increases in sales and earnings

Share this article Share this article GÖTTINGEN, Germany, July 21, 2021 /PRNewswire/ The life science Group Sartorius has continued on its fast growth trajectory, closing the first half of 2021 with significant double-digit increases in both sales revenue and order intake 1. In the first six months of the year, we have seen unabated high demand for innovative technologies used in the development and production of biopharmaceuticals. Orders from customers who manufacture coronavirus vaccines and coronavirus test kits have played an additional important, though not dominant, role in this respect. The acquisitions closed in 2020 also are performing well and have added positive momentum. Our most recent acquisition of a majority stake in CellGenix, a leading global supplier of GMP–grade cell culture components, enables us to provide our customers with even more comprehensive support in moving their drug candidates quickly and efficiently through the various steps of drug devel

Puerto ricoSouth koreaRainer lehmannPetra kirchhoffJoachim kreuzburgAsia pacificWatersep bioseparationsHead of corporate communications investor relationsGroup sartoriusGroup lab products services divisionLab products servicesLab products services divisionBioprocess solutions divisionSartorius groupBioprocess solutionsExecutive board chairman

Sartorius weiter mit hohem Wachstumstempo - deutlich zweistelliger Umsatz- und Ertragsanstieg

Sartorius weiter mit hohem Wachstumstempo - deutlich zweistelliger Umsatz- und Ertragsanstieg Göttingen, Deutschland (ots/PRNewswire) - - Auftragseingang +82,4 Prozent, Umsatz +60,1 Prozent, operative Ertragsmarge 34,1 Prozent - Dynamisches organisches Wachstum im Basisgeschäft beider Sparten, verstärkt durch Impulse im Zusammenhang mit der Coronavirus-Pandemie sowie aus Akquisitionsbeiträgen - Prognose für das Jahr 2021 Anfang Juli erneut angehoben Der Life-Science-Konzern Sartorius hat das hohe Wachstumstempo des Jahresanfangs fortgesetzt und das erste Halbjahr 2021 mit signifikant zweistelligen Steigerungsraten bei Umsatz und Auftragseingang1 abgeschlossen. Wir haben in den ersten sechs Monaten des Jahres eine ungebrochen hohe Nachfrage nach innovativen Technologien für die Entwicklung und Produktion von Biopharmazeutika gesehen. Der Bedarf aus den Bereichen Coronavirus-Impfstoffe und Coronatests hat eine wichtige zusätzliche, aber keine dominante Rolle gespielt.

United statesSouth koreaRainer lehmannJune decJohn sartoriusAsia pacificInvestment program for the yearPercentage group salesBusiness development of saveds divisionGroup salesDrug developmentAreas developmentHalf year sartorius groupSartorius groupS divisionBusiness development

Sartorius with first-quarter uptick in sales and earnings

Sartorius with first-quarter uptick in sales and earnings Read full article Oops! Order intake up 89.2 percent; sales revenue up 61.6 percent; underlying EBITDA margin 33.3 percent 20 percentage points of sales growth influenced by the coronavirus pandemic Accelerated expansion of production capacities in all regions on track as planned Sartorius Logo The life science group Sartorius had an exceptionally strong start in fiscal 2021 and grew substantially in order intake 1, sales revenue and earnings. Businesses related to the coronavirus pandemic additionally fueled this growth. Many of our products play an essential role in helping to overcome the pandemic. In addition to a very positive general business performance in the first quarter, we accordingly experienced strong demand for our products and technologies used in the development and production of vaccines as well as of coronavirus tests and achieved a sharp increase in sales. The substantial rise in the company s p

Puerto ricoSouth koreaRainer lehmannPetra kirchhoffJoachim kreuzburgAsia pacificWatersep bioseparationsHead of corporate communications investor relationsGroup lab products services divisionLab products servicesLab products services divisionBioprocess solutions divisionSartorius groupBioprocess solutionsDanaher corporationExecutive board chairman

Sartorius weiter mit hoher Nachfrage wegen Corona-Krise - Sartorius-Aktie tiefrot

Sartorius weiter mit hoher Nachfrage wegen Corona-Krise - Sartorius-Aktie tiefrot
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

South koreaRainer lehmannDivision in priorShow of exchangeGroup boss crossBusiness developmentSartorius shareSartorius reservedGroup boss cross burgQuarterly wednesdayMiddle marchQuarterly payEnd marchMidweek gainsBeginning of the yearCourse plus

ROUNDUP 2: Laborausstatter Sartorius weiter mit hoher Nachfrage wegen Corona

ROUNDUP 2: Laborausstatter Sartorius weiter mit hoher Nachfrage wegen Corona
boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.

South koreaLower saxonyRainer lehmannDivision in priorShow of exchangeGroup boss crossBusiness developmentConference callClosing priceGroup boss cross burgQuarterly wednesdayMiddle marchSartorius shareQuarterly payEnd marchMidweek gains